Kemik, O. Et Al. 2013. The relationship between serum tumor-associated trypsin inhibitor levels and clinicopathological parameters in patients with gastric cancer. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , vol.17, no.21 , 2923-2928.

Kemik, O., Kemik, A., Sumer, A., Almalı, N., Gurluler, E., Gures, N., ... Purisa, S.(2013). The relationship between serum tumor-associated trypsin inhibitor levels and clinicopathological parameters in patients with gastric cancer. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , vol.17, no.21, 2923-2928.

Kemik, O. Et Al. "The relationship between serum tumor-associated trypsin inhibitor levels and clinicopathological parameters in patients with gastric cancer," EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , vol.17, no.21, 2923-2928, 2013

Kemik, O. Et Al. "The relationship between serum tumor-associated trypsin inhibitor levels and clinicopathological parameters in patients with gastric cancer." EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , vol.17, no.21, pp.2923-2928, 2013

Kemik, O. Et Al. (2013) . "The relationship between serum tumor-associated trypsin inhibitor levels and clinicopathological parameters in patients with gastric cancer." EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , vol.17, no.21, pp.2923-2928.

@article{article, author={O. Kemik Et Al. }, title={The relationship between serum tumor-associated trypsin inhibitor levels and clinicopathological parameters in patients with gastric cancer}, journal={EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES}, year=2013, pages={2923-2928} }